Hamilton Lane Incorporated Class A Stock News

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of bot...

NEW YORK--(BUSINESS WIRE)--73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Alternative Asset Management space, has successfully closed a $55m Series B. The round was led by Growth Equity at Goldman Sachs Alternatives, with continued investment from Blackstone Innovations Investments and participation...

BOSTON, MA--(BUSINESS WIRE)--PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled services companies to capitalize on transformational growth, today announced that it has closed two new funds, totaling $8 billion in capital commitments. PSG's sixth North American flagship fund, PSG VI, closed with $6 billion in capital commitments, surpassing its...

Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was muted, up just 6% year over year. While growth is expected to slowdown in the coming quarters, shares remain richly valued at 34.6 times earnings.

CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 1,572,536 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $252 million.

CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 1,572,536 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations.

The Fund features a high-quality venture portfolio targeting top-performing, oversubscribed funds and companies CONSHOHOCKEN, Pa. , Feb. 6, 2025 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the final close of its Venture Access Fund ("VAF" or "the Fund"), which successfully exceeded its target fund size, raising $615.3 mi...